Position in PFE
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$1,810,719
-$535,841 QoQ
Shares Held
75,196
-10.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.32%
of 13F equity value
Holder Rank
#1,006
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 98%
Shared 2%
None 1%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CHICAGO TRUST Co NA holds $42,770,408 across 10 Drug Manufacturers - General names. PFE ranks #6 (4.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
55,260 | $13,905,626 | |
| 2 | LLY |
ELI LILLY & Co
|
7,888 | $9,461,103 | |
| 3 | JNJ |
Johnson & Johnson
|
21,762 | $5,526,895 | |
| 4 | MRK |
Merck & Co., Inc.
|
42,935 | $5,517,147 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
44,250 | $2,549,684 | |
| 6 | PFE |
Pfizer Inc
This page
|
75,196 | $1,810,719 | |
| 7 | NVS |
Novartis AG
|
8,320 | $1,303,909 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
9,103 | $1,150,072 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,810,719 | 75,196 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $2,346,560 | 83,567 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $1,965,033 | 78,917 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,575,581 | 61,836 | Shares | Sole | 2025-10-10 | |
| 2025-06-30 | $1,437,771 | 59,314 | Shares | Sole | 2025-07-14 | |
| 2025-03-31 | $1,065,901 | 42,064 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $1,107,600 | 41,749 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $1,080,879 | 37,349 | Shares | Sole | 2024-10-10 | |
| 2024-06-30 | $1,045,947 | 37,382 | Shares | Sole | 2024-07-11 | |
| 2024-03-31 | $1,160,782 | 41,830 | Shares | Sole | 2024-04-12 | |
| 2023-12-31 | $991,239 | 34,430 | Shares | Sole | 2024-01-16 | |
| 2023-09-30 | $1,760,066 | 53,062 | Shares | Sole | 2023-10-27 | |
| 2023-06-30 | $1,999,683 | 54,517 | Shares | Sole | 2023-07-19 | |
| 2023-03-31 | $2,287,941 | 56,077 | Shares | Sole | 2023-04-11 | |
| 2022-12-31 | $3,805,338 | 74,265 | Shares | Sole | 2023-01-12 | |
| 2022-09-30 | $3,659,998 | 83,638 | Shares | Sole | 2022-10-13 | |
| 2022-06-30 | $4,530,161 | 86,404 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $4,378,343 | 84,573 | Shares | Sole | 2022-04-12 | |
| 2021-12-31 | $5,195,100 | 87,978 | Shares | Sole | 2022-01-18 | |
| 2021-09-30 | $3,474,690 | 80,788 | Shares | Sole | 2021-10-13 | |
| 2021-06-30 | $2,903,008 | 74,132 | Shares | Sole | 2021-07-21 | |
| 2021-03-31 | $2,236,078 | 61,719 | Shares | Sole | 2021-04-12 | |
| 2020-12-31 | $2,156,218 | 58,577 | Shares | Sole | 2021-01-28 | |
| 2020-09-30 | $2,049,215 | 55,837 | Shares | Sole | 2020-10-08 | |
| 2020-06-30 | $1,793,400 | 54,844 | Shares | Sole | 2020-07-13 | |
| 2020-03-31 | $1,800,484 | 55,162 | Shares | Sole | 2020-04-07 | |
| No filing history on record for this holder in this stock. | ||||||